FSSAI infant formula rules: what the IMS Act 1992 bans, from ads to free samples

By Prakhar Shahi

Published · Updated

Flow chart from the IMS Act 1992 and FSSAI's 2020 rules to notices on Nestle and four others, show cause, and penalties

FSSAI served show-cause notices on Nestle India and four other companies on 21 October 2026 over formula claims and an Instagram reel. India's 1992 law bans advertising and promoting infant milk substitutes. What it forbids, the penalties, and study notes.

Original report · Explained

What do FSSAI's infant formula rules ban? The Infant Milk Substitutes Act 1992 (IMS Act) bars any advertisement or promotion of infant milk substitutes, feeding bottles and infant foods, as well as free samples, gifts to mothers and gifts or funding for health workers; FSSAI's 2020 infant nutrition regulations require every infant food to comply with it (Government of India, 1992; FSSAI, 2024). On 21 October 2026, the Food Safety and Standards Authority of India (FSSAI) served show-cause notices on Nestle India, Abbott Healthcare, Nutricia International, Mead Johnson Nutrition (India) and Zydus Wellness over product claims and promotion, The New Indian Express reported (The New Indian Express, 2026).

For Nestle, FSSAI sought proof for a Lactogen Pro 1 claim that its whey is "easy to digest", and questioned a Nan Excella Pro Stage 1 claim that "5 HMOs helps support the normal immune system", which it read as linking the product to a physiological condition (The New Indian Express, 2026). It also flagged an Instagram "Top 5" reel that recommended five infant formulas as an alleged breach of the IMS Act and the infant nutrition regulations. Zydus Wellness faces questions over "2X faster growth" claims for a growth drink under the 2018 advertising and claims rules.

These are allegations: each company has been asked to show why action should not be taken under the Food Safety and Standards (FSS) Act 2006, and no reply has been made public. See how every outlet covered the infant formula notices.

The law exists to protect breastfeeding. In the National Family Health Survey's fifth round (NFHS-5), 63.7% of children under 6 months were exclusively breastfed, up from 54.9% in NFHS-4 (International Breastfeeding Journal, 2023). That still leaves about one in three infants under 6 months who are not (100 minus 63.7 is 36.3%).

What it is

The IMS Act regulates the production, supply and distribution of baby milk products, with the stated aim of protecting breastfeeding.

Background and timeline

The law has been in force for 33 years, and FSSAI has acted under it twice in five weeks.

What the law says

The Act reaches the advert, the free sample, the clinic and the label.

IMS Act 1992, as amended in 2003

FSS (Foods for Infant Nutrition) Regulations 2020

The Constitution

Institutions and enforcement

Two laws, one regulator: the notices come under the FSS Act, and the conduct rules come from the IMS Act.

The numbers

Five companies, five named formulas in one reel, and more than 150 food makers noticed in recent months.

Arguments for and against

FSSAI says formula claims need a legal basis; the companies have not yet answered in public.

What happens next

The companies must now answer. Each has to submit documents and evidence within the stipulated period, which the reports do not state, and FSSAI will then decide on action under the FSS Act (The New Indian Express, 2026).

Still unknown: the companies' replies, the deadline and any penalty. FSSAI named none in the 21 October reports.

Questions people are asking

Is advertising infant formula legal in India?

No. Section 3 of the IMS Act bars any advertisement or promotion of infant milk substitutes, feeding bottles and infant foods (Government of India, 1992).

Can formula companies give gifts to doctors or fund seminars?

No. Section 9 bars gifts or funding for health workers, and section 8 bars promotion in the health care system (Government of India, 1992).

What must an infant formula label say?

"IMPORTANT NOTICE" and "MOTHER'S MILK IS BEST FOR YOUR BABY", in capitals at least 5 mm high, on the front of the pack (FSSAI, 2024).

Which companies got FSSAI notices on 21 October 2026?

Nestle India, Abbott Healthcare, Nutricia International, Mead Johnson Nutrition (India) and Zydus Wellness (The New Indian Express, 2026).

For students

GS paper: GS Paper II (health; government policies and interventions).

Key terms

Prelims facts

Mains practice question (250 words)

India's IMS Act 1992 bans the promotion of infant milk substitutes to protect breastfeeding. In the light of FSSAI's October 2026 notices, including one over a social media reel, examine whether the law is equipped for digital marketing, and suggest changes.

Prelims practice question

Under India's rules on infant milk substitutes, which of the following must appear on the label? (a) "Clinically proven" (b) "Mother's milk is best for your baby" (c) "Humanised milk" (d) "Equivalent to mother's milk"

Answer: (b). "Humanised" is barred by Regulation 4(2), and a claim of equivalence to mother's milk is barred by section 3 of the IMS Act.

How we did this

We read the IMS Act as published by B&B Associates and in BPNI's copy of the amended Act, and FSSAI's Foods for Infant Nutrition Regulations, and listed what they ban against the allegations in the 21 October 2026 report by The New Indian Express and the September action reported by Business Today. The breastfeeding figures come from a study in the International Breastfeeding Journal. We did not see the notices themselves. A Mid-Day headline also names Hindustan Unilever; the New Indian Express list does not, and we could not confirm a notice to it. We have not named the Instagram creator.

References

This story was produced, reviewed, edited and verified by the reporter before publication, with AI assistance where required.

Covered by 11 outlets across the spectrum: 9% left, 36% center, 9% right.

Who is covering this story

Sources

What an outlet bias classification means

More original reports

Related stories